Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia

NCT04103450 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
276
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Urovant Sciences GmbH